CELU
Celularity IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$35.47M
P/E Ratio
—
EPS
$-3.33
Beta
0.70
52W High
$4.35
52W Low
$1.01
50-Day MA
$1.27
200-Day MA
$1.92
Dividend Yield
—
Profit Margin
-198.80%
Forward P/E
—
PEG Ratio
—
About Celularity Inc
Celularity Inc. is an innovative biotechnology company dedicated to pioneering regenerative medicine through its proprietary cellular products derived from the placenta. The firm boasts a robust pipeline of next-generation immunotherapies, including allogeneic off-the-shelf solutions, targeted at improving treatment efficacy and minimizing complications for cancer and other serious diseases. Supported by a seasoned leadership team and strategic collaborations, Celularity is strategically positioned to meet substantial unmet medical needs, thereby establishing itself as a pivotal entity in the dynamic landscape of advanced therapeutics.
Fundamentals
| Revenue (TTM) | $40.58M |
| Gross Profit (TTM) | $20.54M |
| EBITDA | $-41.35M |
| Operating Margin | -243.20% |
| Return on Equity | -6367.00% |
| Return on Assets | -25.00% |
| Revenue/Share (TTM) | $1.69 |
| Book Value | $-0.71 |
| Price-to-Book | 9.89 |
| Price-to-Sales (TTM) | 0.87 |
| EV/Revenue | 2.516 |
| EV/EBITDA | -36.78 |
| Quarterly Earnings Growth (YoY) | -61.30% |
| Quarterly Revenue Growth (YoY) | -43.20% |
| Shares Outstanding | $28.84M |
| Float | $18.42M |
| % Insiders | 36.55% |
| % Institutions | 12.96% |
Historical Volatility
HV 10-Day
50.18%
HV 20-Day
52.38%
HV 30-Day
60.71%
HV 60-Day
66.76%
HV Rank
—
Volatility is currently contracting
Data last updated: 4/20/2026